Intravenous iron infusion - indications, risks

An intravenous iron infusion is often confused with a vitamin drip, and the two have little in common. A vitamin drip is bought as a service. Intravenous iron is a prescription medicine, usually ferric carboxymaltose, ferric derisomaltose or iron sucrose, given once blood tests confirm the deficiency, administered by medical staff, with the patient kept under observation for at least 30 minutes after the infusion ends. The difference is not a formality: a single infusion delivers up to 1000 mg of iron straight into the bloodstream, and the risk of a serious drop in blood phosphate reaches 75% in clinical trials with one preparation and 8% with another. Such an infusion helps in a handful of well described situations, requires assessment based on test results, and carries side effects: the common mild ones and the rare serious ones. Sometimes a low test result is not an indication for a drip at all. The picture is different again in people who drink heavily, where an identical ferritin reading leads to entirely different conclusions.

In brief

• Intravenous iron is a prescription medicine used for a confirmed deficiency when oral preparations do not work, are not tolerated, or absorption from the gut is impaired.
• A single dose reaches 1000 mg of iron or 20 mg per kilogram of body weight, the infusion itself takes a few to fifteen minutes, and the patient stays under observation for another half hour.
• The most common serious adverse reaction is not an allergy but a fall in blood phosphate after ferric carboxymaltose, reported in trials in 50-92% of those treated.
• In people who drink heavily ferritin is usually inflated by liver damage and inflammation, so a single result is not enough to decide on an infusion.

When is an iron infusion genuinely needed?

Intravenous iron is used for a deficiency confirmed by laboratory tests, when oral treatment fails or stores have to be rebuilt quickly. It is not a procedure for a general boost, nor a substitute for a well planned diet in someone with a normal blood count.

Iron deficiency anaemia is the most common nutritional deficiency in the world. According to WHO figures for 2019 it affected 30% of non-pregnant women aged 15-49, that is 539 million people, and 37% of pregnant women. The vast majority of these cases are treated orally, because that is cheaper and safer. The intravenous route comes into play when there is a specific reason:

• oral preparations are not tolerated, because nausea, constipation and abdominal pain make it impossible to finish a course lasting several months;
• absorption from the gut is impaired: coeliac disease, atrophic gastritis, a state after gastric resection or bariatric surgery;
• a chronic inflammatory process is under way, as in inflammatory bowel disease and chronic kidney disease, which blocks the uptake of iron from food;
• blood loss is ongoing: heavy periods, bleeding from the digestive tract;
• stores have to be rebuilt fast, for instance before surgery, in severe postpartum anaemia, or where the alternative is a blood transfusion;
• heart failure with iron deficiency has been diagnosed, where replacing iron improved exercise capacity in randomised trials (Keating, Drugs 2015, PMID 25428711).

Which results qualify a patient for an infusion?

The starting point is ferritin, together with a full blood count, transferrin saturation and a marker of inflammation. WHO takes ferritin below 15 µg/l in a healthy person over the age of 15 as a sign of exhausted iron stores, and raises the threshold to 70 µg/l where infection or inflammation is present (WHO guideline, 2020). Trials of intravenous iron enrolled patients with haemoglobin below 11 g/dl and ferritin below 100 ng/ml who had not responded to a month of oral treatment (Wolf et al., JAMA 2020, PMID 32016310). The units are written in different ways, but µg/l and ng/ml are exactly the same value, so there is nothing to convert on a laboratory report.

Before anyone offers a drip, it is worth having the full set of results, described in our piece on which blood tests are worth doing. Ferritin alone, without a blood count and without CRP, leads to wrong conclusions in both directions.

How does an iron infusion differ from a vitamin drip?

These are two different categories: intravenous iron is a medicine dispensed on prescription and given under supervision, while a vitamin drip is a lifestyle medicine service with vitamins and electrolytes.

Preparations for intravenous use are complexes of iron with a carbohydrate: the metal is released gradually and does not enter the blood as a large quantity of free ions. The stability of that complex determines both the permitted single dose and the adverse reaction profile, which is why ferric carboxymaltose is not swapped for ferric derisomaltose dose for dose. Vitamin drips do a different job: they replace water soluble vitamins and fluids, and we take apart the difference in uptake between the two routes in our article on whether an intravenous infusion really absorbs better than a tablet.

The vitamin drips in our range do not contain iron. An iron infusion requires a prescription, assessment based on results and facilities in case of a hypersensitivity reaction, so it is not a procedure ordered to your home along with vitamin C.

What does an iron infusion look like step by step?

The visit consists of assessment, the administration itself and observation. The whole procedure usually takes an hour to an hour and a half, although the fluid runs into the vein far more quickly.

1. The doctor reviews the results, coexisting conditions and current medicines, rules out contraindications and calculates the dose from body weight and haemoglobin concentration.
2. The preparation is diluted in saline, a cannula is inserted, blood pressure and pulse are checked.
3. The infusion runs slowly and staff watch the patient throughout, because most reactions appear in the first minutes.
4. After administration the patient stays under care for at least 30 minutes. The summary of product characteristics requires this, and there is a practical reason: most acute reactions reveal themselves in that window.
5. Haemoglobin is reassessed no earlier than 4 weeks after the last dose, because that is how long red cell production and iron incorporation take. Ferritin measured straight after the infusion is inflated and does not reflect real stores.

How long does the infusion take and how much iron is given at once?

For ferric carboxymaltose the maximum single dose is 1000 mg of iron or 20 mg per kilogram of body weight, and no more than 1000 mg over a week. Infusion time depends on the dose: portions of 100-200 mg have no required minimum, doses above 200 up to 500 mg are given over at least 6 minutes, and above 500 up to 1000 mg over at least 15 minutes (Ferinject SmPC, 2020). Given as an injection rather than a drip, the limit is lower at 15 mg per kilogram. With iron sucrose single doses are several times smaller, so replacing the stores fully takes a series of visits instead of one or two.

What are the side effects of an iron infusion?

Most adverse reactions are mild and transient, but two problems deserve separate treatment: the drop in phosphate and hypersensitivity reactions.

Common effects include nausea, reported by 2.9% of participants in clinical trials of ferric carboxymaltose, along with headache, dizziness, facial flushing and a rise in blood pressure. Vomiting, abdominal pain and a fast heart rate appear less often. Some complaints arrive with a delay, a day or two after the procedure, as muscle and joint pain with a low grade fever, and they resolve on their own. A separate and unpleasant technical complication is extravasation of the preparation outside the vein, which leaves a brown skin discolouration lasting months.

Hypophosphataemia, the complication that is rarely mentioned

Ferric carboxymaltose stimulates the release of fibroblast growth factor 23, which triggers loss of phosphate through the kidneys. In a randomised trial hypophosphataemia occurred in 50.8% of patients after ferric carboxymaltose against 0.9% after ferumoxytol, and in 29.1% of those treated with carboxymaltose phosphate was still low after five weeks (Wolf et al., JCI Insight 2018, PMID 30518682). In two twin trials comparing carboxymaltose with ferric derisomaltose the rates were 75.0% and 73.7% against 7.9% and 8.1% (JAMA 2020, PMID 32016310), and in a trial in patients with inflammatory bowel disease 51.0% against 8.3% (Zoller et al., Gut 2023, PMID 36343979). A 2025 systematic review sums up the gap as 50-92% for carboxymaltose and 2-8% for the other preparations. The authors list weakness, bone and muscle pain, and in extreme cases osteomalacia and fractures (Magagnoli et al., Am J Hematol 2025, PMID 39935027).

The summary of product characteristics recommends monitoring phosphate in people given repeated high doses and in patients with risk factors, and where hypophosphataemia persists it requires the need for further carboxymaltose treatment to be reconsidered. The trouble is that the symptoms of phosphate deficiency, fatigue and muscle pain, look exactly like the anaemia the iron was given for.

Reactions during the infusion: from flushing to anaphylaxis

The most common acute reaction is the Fishbane reaction: transient facial flushing with tightness in the chest and back, without hives and without a drop in blood pressure. It is not an IgE mediated allergy but a response to labile iron, it resolves once the infusion is stopped and usually does not recur on a slower repeat administration. A Canadian expert consensus advises against giving diphenhydramine in these situations, because the drug worsens the symptoms and can lower blood pressure (Lim et al., Vox Sanguinis 2019).

Anaphylactic reactions are rare but real, which is why intravenous iron is given only where equipment and staff for resuscitation are available. The product characteristics also list isolated cases of Kounis syndrome, an acute coronary syndrome in the course of a hypersensitivity reaction. Any episode of breathlessness, itching, hives or falling blood pressure during the infusion means the administration must be stopped at once.

When must an iron infusion not be given?

Contraindications are hypersensitivity to the preparation or serious hypersensitivity to other parenteral iron, anaemia not caused by iron deficiency (microcytic anaemia, for instance), and signs of iron overload or disturbed iron utilisation. Ferric carboxymaltose is also not used in children under 14, because it has not been studied in that group.

That last point matters most for people who want to raise their iron level without full diagnostic work. Anaemia can stem from vitamin B12 deficiency, chronic disease, haemolysis or thalassaemia, and in each of those cases an infusion will not help while it does burden the body. In hereditary haemochromatosis the mechanism is the reverse: abnormally low hepcidin secretion causes excessive absorption and deposition of the element in organs, and the treatment remains venesection (Powell et al., Lancet 2016, PMID 26975792). Caution is also needed in active infection, chronic liver disease and the first trimester of pregnancy, where these preparations are not used.

Alcohol and iron: why the same ferritin means something else

In someone who drinks heavily, high ferritin does not prove an excess of iron, and a normal result does not rule out a deficiency. Interpreting it requires a blood count, transferrin saturation and liver function tests alongside.

Two opposing mechanisms are at work. On one side alcohol damages hepatocytes and increases inflammation, and ferritin is an acute phase protein, so its concentration rises regardless of real stores. Animal studies show in addition that chronic alcohol exposure lowers hepcidin and increases iron absorption from the duodenum, which favours its accumulation in the liver (Xue et al., Biomed Pharmacother 2022, PMID 36076527). In carriers of haemochromatosis mutations, alcohol is one of the best documented factors accelerating liver damage. On the other side, chronic drinking leads to bleeding from the digestive tract, malnutrition and genuine iron deficiency anaemia.

This is not a theoretical dispute. A randomised trial in patients with cirrhosis after bleeding from oesophageal varices tested both routes of administration. Ferric carboxymaltose raised haemoglobin by 3.65 g/dl over three months against 1.10 g/dl with oral treatment, and iron stores normalised in 84.6% of patients against 21%. At the same time transient hypophosphataemia occurred in 43% of the intravenous group (Tabish et al., Am J Gastroenterol 2024, PMID 38517084). The benefit was clear, then, but paid for with a metabolic complication that had to be monitored.

If drinking is what stands behind the abnormal results, an infusion on its own settles nothing, because the source of the problem stays active. We write more about how alcohol destroys the liver and what shows up in tests in our piece on alcoholic liver disease.

Frequently asked questions about intravenous iron infusions

How much does an iron infusion cost and is it reimbursed?

The cost is made up of the price of the medicine and the price of administration. Ferric carboxymaltose itself costs roughly 340-600 zloty for a 1000 mg vial in Polish pharmacies (pharmacy prices, August 2026), and privately a consultation fee and the cost of giving the infusion come on top. Under treatment financed by the National Health Fund, in a specialist clinic or in hospital, the patient does not pay for the administration itself.

How soon after the infusion do people feel better?

Haemoglobin starts to rise measurably after two to four weeks, and rebuilding stores takes several weeks longer. Fatigue lifts at varying speed: in a comparative trial improvement was slower in people whose phosphate fell more sharply after the infusion (Gut 2023, PMID 36343979).

Can an iron infusion be given in pregnancy?

The product characteristics limit ferric carboxymaltose to the second and third trimester, and only where the expected benefit outweighs the risk to mother and fetus. Anaemia in the first trimester is treated with oral preparations. The decision rests with the doctor managing the pregnancy, based on results, and the baby needs monitoring during the infusion, because transient fetal bradycardia has been described after parenteral iron.

Can an iron infusion be repeated?

Yes. Where the deficiency persists, further doses are given, keeping to the weekly limit and the intervals recommended in the product characteristics. Before each further dose, ferritin, the blood count and phosphate are checked, so as not to cause iron overload or chronic hypophosphataemia.

Would a vitamin drip do instead of an iron infusion?

No, not if the problem is iron deficiency. A vitamin drip contains no iron and will not raise ferritin or haemoglobin. It replaces B vitamins, vitamin C and fluids, which answers an entirely different problem than anaemia.

This article is for information only and does not replace a medical consultation. Assessment for treatment with intravenous iron is decided by a doctor on the basis of test results and an assessment of your health.